kontakt
- EMA to undertake a review of data as to the AstraZeneca vaccine’s efficacy in preventing COVID-19 disease
- EMA: The AstraZeneca vaccine possibly causes rare, serious symptoms – but remains authorised for use
- COVID-19 Vaccine AstraZeneca: Investigations of blood clots with low numbers of platelets and bleeding continue in Denmark and in the EU
- Status on reviewed reports of suspected side effects of the COVID-19 Vaccine AstraZeneca after vaccination of more than 140,000 Danes
- Status on reviewed reports of suspected side effects of the COVID-19 Vaccine AstraZeneca after vaccination of more than 140,000 Danes
